FILSPARI Trademark

Trademark Overview


On Thursday, July 8, 2021, a trademark application was filed for FILSPARI with the United States Patent and Trademark Office. The USPTO has given the FILSPARI trademark a serial number of 90818374. The federal status of this trademark filing is REGISTERED as of Tuesday, May 2, 2023. This trademark is owned by Travere Therapeutics, Inc.. The FILSPARI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome
filspari

General Information


Serial Number90818374
Word MarkFILSPARI
Filing DateThursday, July 8, 2021
Status700 - REGISTERED
Status DateTuesday, May 2, 2023
Registration Number7044077
Registration DateTuesday, May 2, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2022

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 16, 2021
Primary Code005
First Use Anywhere DateFriday, February 17, 2023
First Use In Commerce DateFriday, February 17, 2023

Trademark Owner History


Party NameTravere Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameTravere Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameTravere Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Tuesday, May 2, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 2, 2023REGISTERED-PRINCIPAL REGISTER
Friday, March 31, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, March 30, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 9, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 22, 2023USE AMENDMENT FILED
Thursday, March 9, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 22, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, December 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 20, 2022SOU EXTENSION 1 GRANTED
Tuesday, December 20, 2022SOU EXTENSION 1 FILED
Tuesday, December 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 28, 2022ASSIGNED TO EXAMINER
Thursday, September 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 12, 2021NEW APPLICATION ENTERED